Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blepharitis

NCT04675242 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Blepharitis

Interventions

DRUG: NCX 4251
DRUG: Placebo

Sponsor

Nicox Ophthalmics, Inc.